All In Biotech

Drug Trial Radar · NCT05178862

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin Followed by Oral Ibrexafungerp Versus Intravenous Echinocandin Followed by Oral Fluconazole (MARIO)

Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

68

Actual

Start

Aug 3, 2022

Primary completion

Nov 7, 2025

Study completion Dec 16, 2025

Sponsor

Lead sponsor
Scynexis, Inc.Industry
Sponsor type
Industry
First posted
Jan 5, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind study of two treatment regimens for invasive candidiasis including candidemia. Subjects will receive intravenous echinocandin followed by oral ibrexafungerp (SCY-078) vs intravenous echinocandin followed by oral fluconazole.

Conditions

  • Candidiasis, Invasive
  • Candidemia

Interventions

  • SCY-078Drug

    Oral ibrexafungerp (SCY-078) as step-down therapy.

  • FluconazoleDrug

    Oral fluconazole (SCY-078) as step-down therapy.

  • EchinocandinDrug

    Intravenous echinocandin

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause MortalityTime frame: Day 30
  2. Global Response at End of Treatment (EU European Medicines Agency [EMA] Only)Time frame: Up to 6 weeks

Locations

101 sites in 13 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham School of Medicine

    Birmingham, Alabama

  • Banner University Medical Center-Tucson

    Tucson, Arizona

  • UC Davis Medical Center

    Sacramento, California

  • UCSF School of Medicine

    San Francisco, California

  • University of Colorado Anschutz Medical Campus

    Denver, Colorado

  • Augusta University Medical Center

    Augusta, Georgia

  • University of Chicago Medical Center

    Chicago, Illinois

  • Ochsner Medical Center

    New Orleans, Louisiana

  • LSU Health Sciences Center

    Shreveport, Louisiana

  • University of Maryland Medical Center

    Baltimore, Maryland

  • Johns Hopkins Hospital

    Baltimore, Maryland

  • University of Michigan Hospital

    Ann Arbor, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • University of Minnesota Medical Center

    Minneapolis, Minnesota

  • Mayo Clinic - Rochester

    Rochester, Minnesota

  • Washington University School of Medicine

    St Louis, Missouri

  • Mercury Street Medical Group, PLLC

    Butte, Montana

  • Duke University

    Durham, North Carolina

  • University of Pennsylvania School of Medicine

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • The Miriam Hospital

    Providence, Rhode Island

  • Houston Methodist Hospital

    Houston, Texas

  • University of Texas Health Science Center at Houston

    Houston, Texas

  • University of Texas MD Anderson Cancer Center

    Houston, Texas

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington

  • Saint Luc University Hospital

    Brussels, Belgium

  • University Hospital Ghent

    Ghent, Belgium

  • University Hospitals Leuven, Campus Gasthuisberg

    Leuven, Belgium

  • University Multiprofile Hospital for Active Treatment "Eurohospital Plovdiv", Plovdiv, Department of Surgery

    Plovdiv, Bulgaria

  • University Multiprofile Hospital for Active Treatment and Emergency Medicine "N.I. Pirogov", Sofia, Clinic of Purulent-Septic Surgery

    Sofia, Bulgaria

  • University Multiprofile Hospital for Active Treatment "Prof. Dr. Stoyan Kirkovich"

    Stara Zagora, Bulgaria

  • Princess Margaret Hospital

    Toronto, Ontario, Canada

  • University Health Network- Toronto General Hospital

    Toronto, Ontario, Canada

  • McGill University Health Centre

    Montreal, Quebec, Canada

  • The First Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, China

  • Qingyuan People's Hospital

    Qingyuan, Guangdong, China

  • The First Affiliated Hospital of Guangzhou Medical University

    Guandong, Guangzhou, China

  • The First Affiliated Hospital of Jinan University

    Guandong, Guangzhou, China

  • Nanfang Hospital of Southern Medical University

    Guangdong, Guangzhou, China

Showing 40 of 101 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.